Abstract
The latest market research report "Global Protein Therapeutics Market
Analysis" by RNCOS provides an exhaustive view on the global protein
therapeutics industry, examining and giving a detailed analysis of the various
protein therapeutics used for disease prevention. The report discusses various
aspects of the Protein Therapeutic Market, such as market size, area of
applications and key geographical markets along with the drivers and
restraints affecting the growth of each segment.
The Protein Therapeutic Market was valued in excess of US$ 57 Billion in 2006
and according to projections, it would grow at a CAGR 12.83% till 2010. The
market is presently dominated by Monoclonal Antibodies and with double-digit
growth projected for future, the segment is expected to bolster its dominant
position. Insulin, Interferon Beta, G-CSF and coagulation factors are also
exhibiting double-digit growth rates.
One of the biggest opportunity areas in the Protein Therapeutics Market will
be in the field of Biogenerics, which is expected to create a multi-billion
dollar market in future.
Key Findings
- US is the largest market for therapeutic proteins in the world followed by
Europe and Japan.
- Insurance reimbursement is a major factor that decides the success of
protein therapeutics.
- Growth in protein therapeutic market will create new opportunities for the
drug discovery Contract Research Organizations (CROs).
- High expenditure on R&D and high rate of failure in phase-3 clinical
trials remains a major challenge for the global protein therapeutics market.
- Until recently, protein therapeutics faced little generic threat; however,
this is likely to change in future with regulatory pathways for the approval
of generics already present in Europe and Asia and to be introduced in US by
2009.
Key Issues and Facts Analyzed
- Evaluation of past, current and future market trends.
- Discussion about the major protein therapeutics and their markets.
- Analysis of key geographical markets.
- Analysis of various challenges and opportunities for the industry.
- Future prospects of the various protein therapeutics segments.
- Profile discussion of key players in this sector.
Key Players Analyzed
This section provides the overview, key facts, and financial information of
prominent players in the global protein therapeutics market, such as Amgen,
Genentech, Roche Group, Merck Serono S.A, Johnson & Johnson, Novo Nordisk A/S
etc.
Research Methodology Used
Information Sources
Information has been sourced from credible sources including books,
newspapers, trade journals, and white papers, industry portals, government
agencies, trade associations, monitoring industry news and developments, and
through access to more than 3000 paid databases.
Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear
regression analysis using software tools, judgmental forecasting, and cause
and effect analysis.
For the purpose of this report, the following segments have been included in
the Protein Therapeutics Market: Monoclonal antibodies, EPO, Interferon' s,
Blood Clotting Factors, HGH, FSH, G-CSF and Insulin
The following currency conversion has been followed in the report:
1 US$ = Euros 0.73, JPY 121
View Cart
